The Clara study was suspended by our sponsor, Ferring Pharmaceuticals, at the start of the COVID-19 pandemic. At the same time, cycle starts for non-study patients were also suspended. Based on recent favorable indicators, we are able to begin procedures the first and second weeks of May for non-study patients. Although currently at a reduced capacity, these scheduled procedures will be increased over the coming weeks. While we have not yet received approval to resume the Clara study, we anticipate recruitment and screening to resume in late June or early July.
As soon as we receive information from the sponsor it will be shared with you. We understand the desire to start the process and continue to work with Ferring to make that possible.
Over the past few weeks, we have implemented numerous processes to maximize patient and staff safety. These include personal protective equipment (PPE) standards for all persons while inside the Center, social distancing through waiting in cars rather than inside, and a phased approach to re-starting procedures. We look forward to seeing each and every one of you back in our offices soon.